Coinfection with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) is
associated with an accelerated course of HCV infection and a faster progression to severe …

BACKGROUND & AIMS: Patients with baseline hepatitis C virus-RNA levels (bHCV-RNA)>
6 log IU/mL or cirrhosis have a reduced probability of a sustained-virologic response (SVR) …

Abstract Background Chronic hepatitis C (CHC) genotype 1b patients with high viral load
are resistant to peginterferon (PEG-IFN) and ribavirin (RBV) combination therapy, especially …

Chemokines have been identified to play an important role in endocrine autoimmune
disease and hepatitis C chronic infection. To our knowledge, no study has evaluated serum …

Drug-induced liver injury (DILI) is an event that has a detrimental impact on drug
development and patient safety; therefore the identification of novel biomarkers that are both …

Interferon-α (IFN-α) are cytokines endowed with multiple biologic effects, including activities
on cells of the immune system, which are important for inducing protective antiviral and …

Nipah virus (NiV) is a recently emerged zoonotic Paramyxovirus that causes regular
outbreaks in East Asia with mortality rate exceeding 75%. Major cellular targets of NiV …

Background: Hepatitis delta is caused by infection with the hepatitis D virus (HDV) and is
considered the most severe form of viral hepatitis. Treatment options for hepatitis delta are …

Chronic hepatitis B virus (HBV) infection may follow four different consecutive phases, which
are defined by virology as well as biochemical markers and differ in terms of prognosis and …

Aim We aimed to examine the relationship between serum Wisteria floribunda agglutinin
positive Mac‐2‐binding protein (WFA+‐M2BP) levels and serum interferon‐γ‐inducible …